How we completed a hemophilia patient recruitment project in just one month [case study]

For people living with hemophilia, a chronic condition in which blood doesn’t clot normally, treatment options are limited and the threat of internal bleeding can be very serious. That’s why research that’s currently underway to identify new and better ways to manage the condition is so important, and why we were excited to support a recent project to push hemophilia research forward. 

Continue reading

Snapshot of diversity, equity, and inclusion in clinical trials [one-pager]

Diversity, equity, and inclusion (DEI) is a hot topic in clinical research — and for good reason. If medications aren’t tested on populations that reflect the real world, how will we know what works best for all patients? In order to understand the importance of this issue, and recognize progress when it comes, we’ve put together a one-pager that provides a snapshot of the current state of ...

Continue reading

National Alzheimer’s Disease Awareness Month and a discussion with the BrightFocus Foundation

November is both National Alzheimer’s Disease Awareness Month and National Family Caregiver Month, a time to show support for the millions of people who are living with Alzheimer’s disease and to honor the invaluable family members and friends serving as Alzheimer’s caregivers. Stacy Pagos Haller, President and CEO of the BrightFocus Foundation, talked to us about why recognizing Alzheimer’s ...

Continue reading

A conversation with the College Diabetes Network

Our partner, the College Diabetes Network (CDN), is a national organization serving thousands of Type 1 Diabetes (T1D) students, their families, and their support networks. We spoke with the CDN to learn more about how they got their start, what they’ve been doing to help the T1D community throughout the COVID-19 pandemic, where they come up with relatable blog content, and why T1D clinical ...

Continue reading

Pros and cons of decentralized clinical trials [infographic]

One alternative clinical trial approach that has gained steam due to the COVID-19 pandemic is the decentralized study, which makes it possible for research to be done virtually. Our infographic below sums up seven advantages and three key weaknesses of decentralized trials:

Continue reading

A Q&A with the GO2 Foundation LungMATCH Navigation Team

November is Lung Cancer Awareness Month (LCAM), an important time of year for the lung cancer community to unite to raise awareness, educate, and spread hope. We spoke with Andrew Ciupek, PhD, Senior Manager, Clinical Research; Rashmi Acharya, MS, Specialist, Science and Research; and Daniel Saez, MSc, Treatment and Trials Navigator – members of the LungMATCH Navigation Team at the GO2 Foundation ...

Continue reading

Clinical trial participation statistics: 3 trends to keep an eye on

In 2020 and 2021, COVID-19 took the world by storm, causing clinical research sponsors to reimagine many aspects of the important studies they conduct, and patient awareness of clinical research to rise exponentially. Clinical trial participation statistics highlight important trends about general perceptions toward research. We look at three sets of statistics from CISCRP’s 2021 Perceptions and ...

Continue reading

What does it mean to be a family caregiver?

November is National Family Caregiver Month, a time to recognize and honor family caregivers across the country. This month is dedicated to the people who put others before themselves with the aim of ensuring that those who are sick, disabled, or elderly feel secure and cared for, often around the clock. We look at what it means to be a family caregiver and how you can help support caregivers. 

Continue reading

5 ways to reduce patient burden in clinical trials

When developing the protocol for a clinical trial, it's important to consider the benefits for patients taking part. At the same time, it's also crucial to consider the possible burden the trial may place on patients. Scheduling difficulties, transportation issues, and confusing directions can all create a negative experience for patients that can ultimately lead to dropouts from your trial.

Continue reading

What is an anal fistula and how is it treated?

A fistula is a narrow tunnel that connects an organ to somewhere else in the body. Developing fistulas is common amongst adults with Crohn’s disease. In fact, about 35-50% of adults with Crohn’s disease will develop a fistula at some point in their disease journey.

Continue reading

Get our latest posts in your inbox.